Harmonium Group Signs an Agreement for Diabetes Investigation with INNOMEDYX Research Center and INSTEAD
May 25, 2017
Diabetes is the 21st century pandemic and one of the leading causes of death. For the first time in history, a non-infectious disease is considered a serious threat to global health.
HARMONIUM will invest in research projects to advance the diagnosis and development of new therapies in the treatment of diabetes, obesity and other pathologies.
"The objective of this alliance is to invest in research projects to advance the diagnosis and development of new therapies in the treatment and prevention of diabetes and its complications, obesity and other associated pathologies, and in the monitoring of Disease through technological solutions accessible to the patient that allow him to help control his illness adequately improving his quality of life "